Cargando…

Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics

Less than half of severe asthmatic patients show a >80% adherence rate to inhaled treatment just before and during biologic therapy. This has implications in biologic treatment sustainability and disease prevalence estimation. http://bit.ly/3cRTJB0

Detalles Bibliográficos
Autores principales:	Caminati, Marco, Vianello, Andrea, Andretta, Margherita, Menti, Anna Michela, Tognella, Silvia, Degli Esposti, Luca, Micheletto, Claudio, Bovo, Chiara, Senna, Gianenrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184111/ https://www.ncbi.nlm.nih.gov/pubmed/32363204 http://dx.doi.org/10.1183/23120541.00017-2020

Ejemplares similares

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience
por: Vianello, A., et al.
Publicado: (2019)

Asthmatic patients in COVID-19 outbreak: Few cases despite many cases
por: Caminati, Marco, et al.
Publicado: (2020)

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
por: Tognella, Silvia, et al.
Publicado: (2021)

Adherence to inhaled corticosteroids by asthmatic patients: measurement and modelling
por: Taylor, Amelia, et al.
Publicado: (2013)

Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy
por: Caminati, Marco, et al.
Publicado: (2019)

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
por: Furci, Fabiana, et al.
Publicado: (2021)

Diagnosis and Management of Allergic Rhinitis in Asthmatic Children
por: Tenero, Laura, et al.
Publicado: (2023)

Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region
por: Perrone, Valentina, et al.
Publicado: (2020)

Achieving good adherence to inhaled corticosteroids after weighing canisters of asthmatic children
por: Chuenjit, Wantida, et al.
Publicado: (2017)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β(2)-Agonist–Inhaled Corticosteroid Rescue
por: Lugogo, Njira, et al.
Publicado: (2023)

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
por: Averell, Carlyne M., et al.
Publicado: (2022)

Breathomics in Asthmatic Children Treated with Inhaled Corticosteroids
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Effects of two inhaled corticosteroid/long-acting beta-agonist combinations on small-airway dysfunction in mild asthmatics measured by impulse oscillometry
por: Diong, Bill, et al.
Publicado: (2013)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
por: Caminati, Marco, et al.
Publicado: (2023)

Oral health in asthmatic patients: a review: Asthma and its therapy may impact on oral health
por: Gani, Federica, et al.
Publicado: (2020)

Hair cortisol and inhaled corticosteroid use in asthmatic children
por: Baan, Esmé J., et al.
Publicado: (2019)

Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids
por: Migueres, Nicolas, et al.
Publicado: (2022)

Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids
por: Butel-Simoes, G.I., et al.
Publicado: (2023)

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
por: Dreher, Michael, et al.
Publicado: (2018)

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry
por: Caminati, Marco, et al.
Publicado: (2022)

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
por: Caminati, M., et al.
Publicado: (2016)

A simple prediction tool for inhaled corticosteroid response in asthmatic children
por: Wu, Yi-Fan, et al.
Publicado: (2017)

Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid
por: Yong, Su-Boon, et al.
Publicado: (2023)

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
por: Caminati, Marco, et al.
Publicado: (2021)

An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
por: Alakeel, Yousif S., et al.
Publicado: (2022)

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
por: Guarnieri, Gabriella, et al.
Publicado: (2022)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
por: Basyigit, Ilknur, et al.
Publicado: (2004)

Bone mineral density in asthmatic patients on inhaled corticosteroids in a developing country
por: Kuan, Yeh Chunn, et al.
Publicado: (2012)

Inhaled corticosteroid treatment for 6 months was not sufficient to normalize phagocytosis in asthmatic children
por: da Silva-Martins, Carmen Lívia Faria, et al.
Publicado: (2013)

Inhaled Corticosteroids as an Associated Risk Factor for Asthmatic Pneumonia: A Literature Review
por: Htun, Zin Mar, et al.
Publicado: (2020)

Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment
por: Mertsch, Pontus, et al.
Publicado: (2022)

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control
por: Caminati, Marco, et al.
Publicado: (2021)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati, Marco, et al.
Publicado: (2019)

Targeting the Small Airways with Inhaled Corticosteroid/Long-Acting Beta Agonist Dry Powder Inhalers: A Functional Respiratory Imaging Study
por: Watz, Henrik, et al.
Publicado: (2021)

Using inhaled corticosteroids can reduce the decline of lung function in asthmatics: pilot study
por: Almeida, Paula, et al.
Publicado: (2015)

Atopy and Inhaled Corticosteroid Use Associate with Fewer IL-17(+) Cells in Asthmatic Airways
por: Fattahi, Fatemeh, et al.
Publicado: (2016)

Bone Density in Asthmatic Patients Taking Inhaled Corticosteroids: Comparison of Budesonide and Beclomethasone Dipropionate
por: Packe, G E, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_3e04di0lnvhk5cgs570k4vac37